ABL is a global leader in immunobiology, offering expert biomarker testing services to advance therapies from discovery to clinical stages.

What do all therapies under development have in common?
Whether in preclinical or clinical stage, they all need robust and reliable biomarker monitoring tools to track and characterize their biological effect.
See how our Biomarker Experts may help you do just that!

Study design

Sampling plans and logistics

Assay development and validation

Integrated approach to utilizing multiple instrument platforms

Efficient study execution and data analysis

Flexible options for alternative study approaches

We support dozens of preclinical and clinical studies evaluating the safety and efficacy of several immunotherapies, including monoclonal antibodies (MAbs), Antibody Drug conjugates (ADCs), therapeutic vaccines, Chimeric Antigen Receptor T cells (CAR-T cells), oncolytic virotherapies, etc.

Neurodegenerative diseases
Alzheimer’s, Parkinson’s, ALS, Multiple Sclerosis, Huntington's

Neurological Disorders

Immuno-oncology
Anti-PD1, Anti-CTLA4, CAR T cells, Neoantigens, Cancer Vaccines

Immuno-oncology

Infectious diseases
HPV, HCV, HBV, HIV, Zyka, Sepsis, Clostridium Difficile

Infectious diseases

Autoimmune conditions
Crohn’s Disease, Rheumatoid Arthritis, Psoriasis, NASH, Diabetes

Other diseases

ABL Lyon is certified according to ISO 9001:2015 standards since October 2011.
In addition to the ISO standards, our QMS is based on Good Laboratory Practices (as revised in 1997 issued by the OCDE), and uses the following referentials as guidance:

GCP: Good Clinical practices (CPMP/ICH/135/95).
GCLP: reflection paper EMA/INS/GCP/532137/2010
GCLP: Good Clinical Laboratory Practices (WHO)
GCLP: Good Clinical Laboratory Practices (RAQ – December 2012)
Communication plan
  • Project Management Meetings
  • Secure Raw data availability
  • Total confidentiality
  • Timely troubleshooting report
  • Questioning unexpected results
Technical Protocol
  • Scientific expertise
  • Understand and Qualify the need
  • Offier the most relevant methods
    • Optimize, validate methods
    • Explore new Approaches
  • Full study report
  • DTS
  • Critical analysis of generated data
  • Secured archiving of study results
Quality plan
  • GCLP / ISO 9001:2015
  • Secured systems (LIMS)
  • Sample management
  • Stringent QC criteria
  • Equipment maintenance
  • Full traceability
International footprint

Wherever you are in your product development pipeline, ABL has established protocols and trained personnel for rapid study set-up at facilities located in the U.S. and Europe.

We can either transfer your method to our labs or our team can work with you to adapt or develop a novel suitable method. In most cases, samples can be assayed on fresh or frozen samples and the results provided to you in a preferred format.

Contact one of our sites today to see how ABL can help you advance your product!

Europe contact U.S. contact